| 6-K | 28-10-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024090964/ea021865001ex99-1_nlspharma.htm | sec.gov | filings |
| F-3 | 23-10-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024089948/ea0218223-f3_nlspharm.htm | sec.gov | filings |
| 6-K | 22-10-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024089638/ea021801601ex10-1_nlspharma.htm | sec.gov | filings |
| D | 21-10-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024089358/xslFormDX01/primary_doc.xml | sec.gov | filings |
| 6-K | 18-10-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024088969/ea021687601ex99-1_nlspharma.htm | sec.gov | filings |
| SC 13G | 15-10-2024 | https://www.sec.gov/Archives/edgar/data/1140358/000121390024087664/ea0217643-13galpha_nlsphar.htm | sec.gov | filings |
| 6-K | 15-10-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024087508/ea021757501ex99-1_nlspharm.htm | sec.gov | filings |
| 6-K | 11-10-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024087049/ea021730601ex99-1_nlspharm.htm | sec.gov | filings |
| 6-K | 11-10-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024087057/0001213900-24-087057.txt | sec.gov | filings |
| 6-K | 10-10-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024086884/0001213900-24-086884.txt | sec.gov | filings |
| 6-K | 08-10-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024086002/0001213900-24-086002.txt | sec.gov | filings |
| 6-K | 01-10-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024084023/0001213900-24-084023.txt | sec.gov | filings |
| 6-K | 25-09-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024081588/ea021530101ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 19-09-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024080258/0001213900-24-080258.txt | sec.gov | filings |
| 6-K | 17-09-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024079063/ea021474001ex10-1_nlspharma.htm | sec.gov | filings |
| 6-K | 13-09-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024078645/ea021370101ex99-1_nlspharma.htm | sec.gov | filings |
| F-1 | 27-08-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024072968/ea0212393-f1_nlspharma.htm | sec.gov | filings |
| 6-K | 26-08-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024072621/ea021235301ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 15-08-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024069614/ea021144701ex16-1_nlspharma.htm | sec.gov | filings |
| 6-K | 14-08-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024068967/0001213900-24-068967.txt | sec.gov | filings |
| 6-K | 30-07-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000101376224002715/ea021021701ex99-1_nlspharma.htm | sec.gov | filings |
| D | 15-07-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024061184/xslFormDX01/primary_doc.xml | sec.gov | filings |
| 424B5 | 01-07-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024057574/ea0208764-424b5_nlspharma.htm | sec.gov | filings |
| 6-K | 01-07-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024057569/ea020872301ex4-1_nlspharma.htm | sec.gov | filings |
| 6-K | 27-06-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024056712/ea020862401ex99-1_nlspharma.htm | sec.gov | filings |
| EFFECT | 26-06-2024 | https://www.sec.gov/Archives/edgar/data/1783036/999999999524001948/xslEFFECTX01/primary_doc.xml | sec.gov | filings |
| 6-K | 25-06-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024055763/ea020847801ex99-1_nlspharm.htm | sec.gov | filings |
| 6-K | 25-06-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024055442/ea020845101ex99-1_nlspharm.htm | sec.gov | filings |
| 6-K | 11-06-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024051717/ea020762701ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 06-06-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024050412/ea020745301ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 31-05-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024048522/0001213900-24-048522.txt | sec.gov | filings |
| F-1 | 30-05-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024047585/ea0206792-f1_nlspharma.htm | sec.gov | filings |
| 6-K | 28-05-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024046825/ea020691201ex99-1_nlsphar.htm | sec.gov | filings |
| 6-K | 24-05-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024046734/ea020680501ex99-1_nlsphar.htm | sec.gov | filings |
| 6-K | 22-05-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024045730/ea020668701ex99-1_nlsphar.htm | sec.gov | filings |
| 20-F | 15-05-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024043570/ea0205871-20f_nlspharma.htm | sec.gov | filings |
| 6-K | 14-05-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024042968/ea020609501ex99-1_nlspharma.htm | sec.gov | filings |
| NT 20-F | 30-04-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024037801/ea0204876-nt20f_nlspharma.htm | sec.gov | filings |
| 6-K | 19-04-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024034569/ea0204274ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 15-04-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024032948/ea020356201ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 08-04-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024031179/0001213900-24-031179.txt | sec.gov | filings |
| D | 03-04-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024029808/xslFormDX01/primary_doc.xml | sec.gov | filings |
| SC 13G | 27-03-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000092963824001262/sch13g.htm | sec.gov | filings |
| 424B5 | 22-03-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024024983/ea0202342-424b5_nlspharma.htm | sec.gov | filings |
| 6-K | 21-03-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024024841/ea020225501ex4-1_nlspharma.htm | sec.gov | filings |
| 6-K | 20-03-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024024197/ea020211001ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 20-03-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024024295/0001213900-24-024295.txt | sec.gov | filings |
| 6-K | 20-03-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024024134/ea020210901ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 14-03-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024022393/ea020175701ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 11-03-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024021393/ea020143601ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 23-02-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024016491/ea0200575ex99-1_nlspharma.htm | sec.gov | filings |
| SC 13G/A | 12-02-2024 | https://www.sec.gov/Archives/edgar/data/1463928/000110465924014697/tm245685d2_sc13ga.htm | sec.gov | filings |
| 6-K | 12-01-2024 | https://www.sec.gov/Archives/edgar/data/1783036/000121390024003419/ea191532ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 29-12-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023099942/ea190759ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 22-12-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023098183/0001213900-23-098183.txt | sec.gov | filings |
| 6-K | 06-12-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023093725/ea189432ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 04-12-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023092738/ea189474-6kex99i_nls.htm | sec.gov | filings |
| 6-K | 04-12-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023092660/ea189393ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 01-12-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023091702/ea189322ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 16-11-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023087912/ea188582ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 25-10-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000101376223006655/ea187266ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 25-10-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000101376223006467/ea187173ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 13-09-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023076364/ea185167ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 30-08-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023072297/ea184282ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 20-07-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023058495/ea181522ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 03-07-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023053971/ea181301ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 14-06-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023048746/ea180350ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 09-06-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023047626/ea180037ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 24-05-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023042747/0001213900-23-042747.txt | sec.gov | filings |
| 6-K | 08-05-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023037100/ea178115ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 05-05-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023036929/0001213900-23-036929.txt | sec.gov | filings |
| 20-F | 05-05-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023036920/f20f2022_nlspharma.htm | sec.gov | filings |
| 6-K | 02-05-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023035157/ea177832ex99-1_nlspharma.htm | sec.gov | filings |
| NT 20-F | 01-05-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023034683/ea177781-nt20f_nlspharma.htm | sec.gov | filings |
| 6-K | 27-03-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023023224/ea175801ex99-1_nlspharma.htm | sec.gov | filings |
| SC 13G | 24-02-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023014126/ea174177-13ggrisard_nlsphar.htm | sec.gov | filings |
| 6-K | 21-02-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023013296/ea173983ex99-1_nlspharma.htm | sec.gov | filings |
| SC 13G/A | 14-02-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023011541/ea173613-13ga1magnet_nlsphar.htm | sec.gov | filings |
| SC 13G/A | 14-02-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023010951/ea173372-13ga1konofal_nls.htm | sec.gov | filings |
| SC 13G/A | 13-02-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023010726/ea173368-13ga1zwyer_nlspharm.htm | sec.gov | filings |
| 6-K | 01-02-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023006685/ea172551ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 25-01-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023005106/ea172161ex99-1_nlspharma.htm | sec.gov | filings |
| EFFECT | 23-01-2023 | https://www.sec.gov/Archives/edgar/data/1783036/999999999523000153/xslEFFECTX01/primary_doc.xml | sec.gov | filings |
| 6-K | 23-01-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023004457/ea171991ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 23-01-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023004289/ea172042ex99-1_nlspharma.htm | sec.gov | filings |
| F-3 | 13-01-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023002775/ea171509-f3_nlspharm.htm | sec.gov | filings |
| 6-K | 12-01-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023002388/ea171572ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 10-01-2023 | https://www.sec.gov/Archives/edgar/data/1783036/000121390023001839/ea171446ex99-1_nlspharma.htm | sec.gov | filings |
| SC 13G/A | 03-01-2023 | https://www.sec.gov/Archives/edgar/data/1463928/000110465923000324/tm231355d6_sc13ga.htm | sec.gov | filings |
| 6-K | 22-12-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022081988/ea170647ex99-1_nlspharma.htm | sec.gov | filings |
| D | 21-12-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022081766/xslFormDX01/primary_doc.xml | sec.gov | filings |
| 6-K | 20-12-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022081374/ea170572ex99-1_nlspharma.htm | sec.gov | filings |
| EFFECT | 16-12-2022 | https://www.sec.gov/Archives/edgar/data/1783036/999999999522003560/xslEFFECTX01/primary_doc.xml | sec.gov | filings |
| SC 13G | 16-12-2022 | https://www.sec.gov/Archives/edgar/data/918923/000092189522003221/sc13g07422nlsp_12162022.htm | sec.gov | filings |
| 6-K/A | 16-12-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022080565/ea170354-6ka1_nlspharma.htm | sec.gov | filings |
| 6-K | 14-12-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022079783/ea170169ex99-1_nls.htm | sec.gov | filings |
| 6-K | 14-12-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022079586/ea170132ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 08-12-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022078494/ea169823ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 07-12-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022078063/ea169759ex99-1_nlspharma.htm | sec.gov | filings |
| F-3 | 06-12-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022077965/ea169650-f3_nlspharm.htm | sec.gov | filings |
| 6-K | 01-12-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022076682/ea169499ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 23-11-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022074725/ea169166ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 14-11-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022071639/ea168548ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 07-11-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022069616/ea168121ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 02-11-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022068418/ea167916ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 28-10-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022067164/ea167731ex99-1_nlspharma.htm | sec.gov | filings |
| D | 14-10-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022063963/xslFormDX01/primary_doc.xml | sec.gov | filings |
| 6-K | 11-10-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022063325/ea166878ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 07-10-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022062787/ea166893ex3-1_nlspharma.htm | sec.gov | filings |
| 6-K | 06-10-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022062468/ea166819ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 03-10-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022060989/ea166644ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 27-09-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022059143/ea166364ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 16-09-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022056621/ea165888ex3-1_nlspharma.htm | sec.gov | filings |
| 6-K/A | 16-09-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022056617/ea165719-6ka1_nlspharma.htm | sec.gov | filings |
| 6-K | 08-09-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022054667/ea165474ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 23-08-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022050535/ea164849ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 28-07-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022042196/ea163468ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 21-07-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022040574/ea163112ex99-1_nlspharma.htm | sec.gov | filings |
| EFFECT | 22-06-2022 | https://www.sec.gov/Archives/edgar/data/1783036/999999999522001834/xslEFFECTX01/primary_doc.xml | sec.gov | filings |
| CORRESP | 17-06-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022033584/filename1.htm | sec.gov | filings |
| UPLOAD | 16-06-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000000000022006584/filename1.pdf | sec.gov | filings |
| 6-K | 10-06-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022032257/ea161406ex99-1_nls.htm | sec.gov | filings |
| F-1 | 10-06-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022032265/ea161364-f1_nlspharma.htm | sec.gov | filings |
| 6-K | 06-06-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022031266/ea161163ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 03-06-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022031201/ea161145ex3-1_nlspharma.htm | sec.gov | filings |
| 6-K | 02-06-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022030831/ea161027ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 01-06-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022030694/0001213900-22-030694.txt | sec.gov | filings |
| 6-K | 11-05-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022025618/ea159747ex99-1_nlspharmac.htm | sec.gov | filings |
| 6-K | 04-05-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022023819/ea159354ex99-1_nlspharmac.htm | sec.gov | filings |
| 6-K | 27-04-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022021747/ea158916ex99-1_nlspharm.htm | sec.gov | filings |
| 6-K | 25-04-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022021444/ea158811ex3-1_nlspharma.htm | sec.gov | filings |
| 424B5 | 14-04-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022019863/ea158426-424b5_nlspharma.htm | sec.gov | filings |
| 6-K | 14-04-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022019870/ea158402ex4-1_nlspharma.htm | sec.gov | filings |
| 424B3 | 13-04-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022019520/ea158373-424b3_nlspharma.htm | sec.gov | filings |
| 6-K | 06-04-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022018466/ea158151ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 01-04-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022017543/ea157809ex99-1_nlspharm.htm | sec.gov | filings |
| 6-K | 31-03-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022016429/ea157660ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 28-03-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022015303/ea157449ex99-1_nlspharma.htm | sec.gov | filings |
| 20-F | 24-03-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022014905/f20f2021_nlspharma.htm | sec.gov | filings |
| 6-K | 16-03-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022012705/ea156904ex99-1_nlspharma.htm | sec.gov | filings |
| 424B5 | 04-03-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022010743/ea156494-424b5_nlspharma.htm | sec.gov | filings |
| 6-K | 04-03-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022010748/ea156463ex1-1_nlspharma.htm | sec.gov | filings |
| SC 13G | 24-02-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022009081/ea156131-13geric_nlsphar.htm | sec.gov | filings |
| SC 13G | 18-02-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022008513/ea155940-13gmagnetic_nlsphar.htm | sec.gov | filings |
| EFFECT | 14-02-2022 | https://www.sec.gov/Archives/edgar/data/1783036/999999999522000432/xslEFFECTX01/primary_doc.xml | sec.gov | filings |
| SC 13G | 14-02-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022007218/ea155466-13gzwyer_nlspharma.htm | sec.gov | filings |
| CORRESP | 10-02-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022006337/filename1.htm | sec.gov | filings |
| UPLOAD | 08-02-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000000000022001584/filename1.pdf | sec.gov | filings |
| 6-K | 07-02-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022005596/ea155020ex99-1_nlspharma.htm | sec.gov | filings |
| F-3 | 03-02-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022005236/ea154797-f3_nlspharma.htm | sec.gov | filings |
| SC 13G/A | 11-01-2022 | https://www.sec.gov/Archives/edgar/data/1463928/000110465922003215/tm222640d2_sc13ga.htm | sec.gov | filings |
| EFFECT | 07-01-2022 | https://www.sec.gov/Archives/edgar/data/1783036/999999999522000079/xslEFFECTX01/primary_doc.xml | sec.gov | filings |
| UPLOAD | 04-01-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000000000022000046/filename1.pdf | sec.gov | filings |
| CORRESP | 04-01-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022000472/filename1.htm | sec.gov | filings |
| 6-K | 04-01-2022 | https://www.sec.gov/Archives/edgar/data/1783036/000121390022000372/ea153384ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 22-12-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021066833/ea152865ex99-1_nlspharma.htm | sec.gov | filings |
| F-1 | 20-12-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021066320/ea152600-f1_nlspharma.htm | sec.gov | filings |
| 6-K | 16-12-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021065560/ea152430ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 15-12-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021065480/ea152430ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 14-12-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021065223/ea152341ex3-1_nlspharma.htm | sec.gov | filings |
| 6-K | 30-11-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021062456/ea151499ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 23-11-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021061404/ea151222ex3-1_nlspharma.htm | sec.gov | filings |
| 6-K | 18-11-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021060540/ea150982ex99-1_nlspharm.htm | sec.gov | filings |
| EFFECT | 04-11-2021 | https://www.sec.gov/Archives/edgar/data/1783036/999999999521004183/xslEFFECTX01/primary_doc.xml | sec.gov | filings |
| CORRESP | 01-11-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021055695/filename1.htm | sec.gov | filings |
| 6-K | 01-11-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021055654/ea149622ex99-1_nlspharma.htm | sec.gov | filings |
| F-1/A | 01-11-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021055655/ea149618-f1a1_nlspharma.htm | sec.gov | filings |
| UPLOAD | 28-10-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000000000021013115/filename1.pdf | sec.gov | filings |
| 6-K | 26-10-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021054618/ea149342ex3-1_nlspharma.htm | sec.gov | filings |
| F-1 | 22-10-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021054182/ea149233-f1_nlspharma.htm | sec.gov | filings |
| 6-K | 14-10-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021052746/ea148843ex99-1_nlspharma.htm | sec.gov | filings |
| SC 13G | 08-10-2021 | https://www.sec.gov/Archives/edgar/data/1463928/000110465921124264/tm2129554d1_sc13g.htm | sec.gov | filings |
| EFFECT | 04-10-2021 | https://www.sec.gov/Archives/edgar/data/1783036/999999999521003735/xslEFFECTX01/primary_doc.xml | sec.gov | filings |
| POS AM | 30-09-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021050776/ea148070-posam_nlspharma.htm | sec.gov | filings |
| 6-K | 28-09-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021050171/ea148010ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 28-09-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021050290/ea147969ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 14-09-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021047893/ea147367ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 19-08-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021043764/ea146152ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 19-07-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021037385/ea144393ex99-1_nlspharm.htm | sec.gov | filings |
| 6-K | 16-07-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021037151/ea144297ex99-1_nlspharm.htm | sec.gov | filings |
| 6-K | 06-07-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021035742/ea143744ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 17-06-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021032952/0001213900-21-032952.txt | sec.gov | filings |
| EFFECT | 07-06-2021 | https://www.sec.gov/Archives/edgar/data/1783036/999999999521002210/xslEFFECTX01/primary_doc.xml | sec.gov | filings |
| POS AM | 27-05-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021029675/ea141808-posam_nlspharma.htm | sec.gov | filings |
| 6-K | 25-05-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021029131/ea141681ex99-1_nlspharma.htm | sec.gov | filings |
| 20-F | 14-05-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021026511/f20f2020_nlspharmaceutics.htm | sec.gov | filings |
| 6-K | 14-05-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021026494/0001213900-21-026494.txt | sec.gov | filings |
| NT 20-F | 30-04-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021023673/ea139997-nt20f_nlspharma.htm | sec.gov | filings |
| 6-K | 06-04-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021020295/ea139080ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 05-04-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021020030/ea138964ex99-1_nlspharma.htm | sec.gov | filings |
| SC 13G/A | 17-03-2021 | https://www.sec.gov/Archives/edgar/data/1131362/000138713121003638/nlsp-sc13ga_031221.htm | sec.gov | filings |
| 6-K | 12-03-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021015011/ea137558ex99-1_nlspharma.htm | sec.gov | filings |
| 6-K | 10-03-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021014574/ea137211ex16-1_nlspharma.htm | sec.gov | filings |
| 6-K | 01-03-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021012374/0001213900-21-012374.txt | sec.gov | filings |
| 6-K | 09-02-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021007520/ea134898ex3-1_nlspharma.htm | sec.gov | filings |
| SC 13G | 04-02-2021 | https://www.sec.gov/Archives/edgar/data/1131362/000138713121001754/nlsp-sc13g_012921.htm | sec.gov | filings |
| 6-K | 02-02-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021006237/ea134404ex3-1_nlspharma.htm | sec.gov | filings |
| POS EX | 02-02-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021005980/ea134192-posex_nlspharma.htm | sec.gov | filings |
| 424B4 | 01-02-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021005637/ea134268-424b4_nlspharma.htm | sec.gov | filings |
| EFFECT | 29-01-2021 | https://www.sec.gov/Archives/edgar/data/1783036/999999999521000316/xslEFFECTX01/primary_doc.xml | sec.gov | filings |
| 6-K | 29-01-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021005188/ea134203ex99-1_nlspharma.htm | sec.gov | filings |
| CERT | 28-01-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000135445721000120/8A_Cert_NLSP.pdf | sec.gov | filings |
| 8-A12B | 28-01-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021004771/ea134057-8a12b_nlsphar.htm | sec.gov | filings |
| CERT | 28-01-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000135445721000119/8A_Cert_NLSP.pdf | sec.gov | filings |
| CORRESP | 25-01-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021004018/filename1.htm | sec.gov | filings |
| CORRESP | 25-01-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021004020/filename1.htm | sec.gov | filings |
| F-1/A | 20-01-2021 | https://www.sec.gov/Archives/edgar/data/1783036/000121390021002942/ea133431-f1a5_nlspharma.htm | sec.gov | filings |
| CORRESP | 19-11-2020 | https://www.sec.gov/Archives/edgar/data/1783036/000121390020038102/filename1.htm | sec.gov | filings |
| UPLOAD | 17-11-2020 | https://www.sec.gov/Archives/edgar/data/1783036/000000000020010991/filename1.pdf | sec.gov | filings |
| F-1/A | 17-11-2020 | https://www.sec.gov/Archives/edgar/data/1783036/000121390020037777/ea130034-f1a4_nlspharma.htm | sec.gov | filings |
| F-1/A | 13-11-2020 | https://www.sec.gov/Archives/edgar/data/1783036/000121390020036675/ea129645-f1a3_nlspharma.htm | sec.gov | filings |
| CORRESP | 19-10-2020 | https://www.sec.gov/Archives/edgar/data/1783036/000121390020031931/filename1.htm | sec.gov | filings |
| F-1/A | 19-10-2020 | https://www.sec.gov/Archives/edgar/data/1783036/000121390020031906/ea128281-f1a2_nlspharma.htm | sec.gov | filings |
| UPLOAD | 17-09-2020 | https://www.sec.gov/Archives/edgar/data/1783036/000000000020008768/filename1.pdf | sec.gov | filings |
| F-1/A | 31-08-2020 | https://www.sec.gov/Archives/edgar/data/1783036/000121390020024460/ea125945-f1a1_nlspharma.htm | sec.gov | filings |
| CORRESP | 31-08-2020 | https://www.sec.gov/Archives/edgar/data/1783036/000121390020024462/filename1.htm | sec.gov | filings |
| UPLOAD | 03-03-2020 | https://www.sec.gov/Archives/edgar/data/1783036/000000000020001944/filename1.pdf | sec.gov | filings |
| F-1 | 28-02-2020 | https://www.sec.gov/Archives/edgar/data/1783036/000121390020005070/ea119052-f1_nlspharma.htm | sec.gov | filings |
| DRSLTR | 20-02-2020 | https://www.sec.gov/Archives/edgar/data/1783036/000121390020004455/filename1.htm | sec.gov | filings |
| DRS/A | 20-02-2020 | https://www.sec.gov/Archives/edgar/data/1783036/000121390020004454/filename1.htm | sec.gov | filings |
| UPLOAD | 15-01-2020 | https://www.sec.gov/Archives/edgar/data/1783036/000000000020000359/filename1.pdf | sec.gov | filings |
| DRS | 18-12-2019 | https://www.sec.gov/Archives/edgar/data/1783036/000121390019026448/filename1.htm | sec.gov | filings |
